Alice Sagwidza-Tembe, CNS Correspondent, Swaziland
Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are global challenges. Treatment of both requires prolonged and toxic therapies. Centralised inpatient treatment, delivered by specialist doctors and nurses in a specialised hospital, is still a common practice in many MDR-TB high-burden countries.
Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are global challenges. Treatment of both requires prolonged and toxic therapies. Centralised inpatient treatment, delivered by specialist doctors and nurses in a specialised hospital, is still a common practice in many MDR-TB high-burden countries.